EN
HI
Biocon share price chart
Biocon Share Key Metrics
Volume
52.66 L
Market Cap
69107.40 CR
LTQ@LTP
50@426.35
ATP
428.78
Var Margin
15.01 %
Circuit Range
383.75-468.95
Delivery %
25.93 %
Value
225.79 CR
ASM/GSM
No
Market Lot
1
Summary
BIOCON stock price is ₹426.35 as of 9 Aug, 2026. The stock intraday movement has stayed between ₹425.30 and ₹436.20, while Biocon share price 52 week high low is ₹331.00 & ₹447.15.
In terms of trading activity, BIOCON share price has recorded a volume of 52,65,823 shares. The Biocon has a market cap of ₹1620907773. The stock’s Average Traded Price (ATP) stands at ₹428.78, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 50 @ ₹426.35.
The Biocon upper circuit limit is ₹468.95 & The Biocon lower circuit limit is ₹383.75, with a Value of ₹225.79 CR. The Delivery Percentage for the day is 25.93%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Biocon Fundamentals
P/E Ratio
141.48
P/B Ratio
2.06
Div. Yield
0.12
Sector P/E
64.26
Sector P/B
3.23
Sec. Div. Yield
0.51
Biocon Resistance and Support
Pivot 433.45
Resistance
First Resistance
445.65
Second Resistance
454.7
Third Resistance
466.9
Support
First Support
424.4
Second Support
412.2
Third Support
403.15
Biocon Futures & Options
Biocon Option Chain
View Price, OI, Greeks & More...
25AUG26
428.90
-11.40 (2.59%)
29SEP26
431.55
-11.40 (2.57%)
27OCT26
433.80
-11.25 (2.53%)
BIOCON|25AUG26 CE 425.00
12.40
-8 (-39.22%)
BIOCON|25AUG26 PE 430.00
11.5
4.9 (74.24%)
Biocon Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 07 2026 | 430 | 426.35 | -2.35% | 436.2 | 425.3 |
| Thu Aug 06 2026 | 428 | 436.6 | 2.68% | 442.5 | 421.25 |
| Wed Aug 05 2026 | 426 | 425.2 | 0.76% | 428.64 | 422.29 |
Biocon Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-10-01 | Redemption (Part) of NCD |
| 2025-08-07 | Quarterly Results |
| 2025-05-08 | Audited Results & Final Dividend |
| 2025-04-23 | Others |
| 2025-04-04 | To consider Fund Raising |
| 2025-01-30 | Quarterly Results & Others |
| 2025-01-27 | Others |
| 2024-10-30 | Quarterly Results |
Biocon News
Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Biocon is scheduled to interact with analysts and institutional investors virtually at the Emkay Confluence 2026 on August 12, 2026. No Unpublished Price Sensitive Information will be disclosed during this group interaction.
Aug 07 2026 20:33:07
Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
Biocon's material subsidiary, Biocon Biologics Limited, announced the resignation of its statutory auditors, B S R & Co. LLP, effective August 6, 2026. This change is due to the mandatory rotation policy to align the auditors of the subsidiary with the holding company.
Aug 06 2026 23:15:21
Read More
Biocon Management
| Name | Position |
|---|---|
| Kiran Mazumdar-Shaw | Chairperson |
| Ravi Rasendra Mazumdar | Non Independent & Non Executive Director |
Biocon Similar Stocks
Aurobindo Pharma Ltd.
1658.00
69.10 (4.35%)
Manipal Health Enterprises Ltd.
677.95
27.45 (4.22%)
Aster DM Quality Care Ltd.
869.70
25.25 (2.99%)
Fortis Healthcare Ltd.
955.15
35.15 (3.82%)
Alkem Laboratories Ltd.
5620.00
22.50 (0.40%)
Glenmark Pharmaceuticals Ltd.
2279.10
9.10 (0.40%)
Abbott India Ltd.
27835.00
-20.00 (0.07%)
Anthem Biosciences Ltd.
841.00
15.35 (1.86%)
Biocon FAQs
The Buying Price of Biocon share is 426.35 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Biocon stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Biocon, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Biocon shares is 141.48. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Biocon shares is 2.06. Useful to assess the stock's value relative to its book value.
To assess Biocon’s valuation compare Sector P/E, P/B which are 64.26 & 3.23 with sector averages, along with growth rates and financial metrics.
The Market Cap of Biocon is 69107.40 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Biocon share price is 447.15 & 331.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Biocon belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
